Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended	9 Months Ended
Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2022	Dec. 31, 2021
Operating expenses
Research and development	$ 2,196,546	$ 1,849,399	$ 6,804,069	$ 5,742,911
General and administrative	1,161,351	1,981,665	3,502,029	5,156,152
Total operating expenses	3,357,897	3,831,064	10,306,098	10,899,063
Loss from operations	(3,357,897)	(3,831,064)	(10,306,098)	(10,899,063)
Other income (expense)	(587)	4	16	368,876
Interest expense		(1,010,247)		(2,204,917)
Loss on debt extinguishment				(1,321,450)
Loss before income taxes	(3,358,484)	(4,841,307)	(10,306,082)	(14,056,554)
Provision for income taxes			1,600	1,600
Net loss	$ (3,358,484)	$ (4,841,307)	$ (10,307,682)	$ (14,058,154)
Net loss per share
Basic and diluted	$ (0.31)	$ (0.76)	$ (0.95)	$ (2.22)
Shares used in computing net loss per share
Basic and diluted	10,925,862	6,354,145	10,863,082	6,331,982

The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.

No definition available.